Terms: = Thyroid cancer AND NTRK1, ENSG00000198400, 4914, P04629, TRK1, MTC, DKFZp781I14186, p140-TrkA, TRKA, TRK AND Prognosis
339 results:
1. Updates on the genetics of multiple endocrine neoplasia.
Sahakian N; Castinetti F; Romanet P; Reznik Y; Brue T
Ann Endocrinol (Paris); 2024 Apr; 85(2):127-135. PubMed ID: 38325596
[TBL] [Abstract] [Full Text] [Related]
2. Measuring discrepancies between simple medullary and synchronous medullary/papillary thyroid carcinomas: a comparative cross-sectional study.
Zhang D; Yang M; Frattini F; Cestari A; Li K; Wang H; Chi H; Sui C; Bai K; Lan D; Dionigi G; Sun H
Front Endocrinol (Lausanne); 2023; 14():1301200. PubMed ID: 38317715
[TBL] [Abstract] [Full Text] [Related]
3. [Precision medicine in endocrinology exemplified by medullary thyroid cancer].
Brandenburg T; Machlah YM; Führer D
Inn Med (Heidelb); 2024 Mar; 65(3):202-210. PubMed ID: 38231404
[TBL] [Abstract] [Full Text] [Related]
4. Survival Outcomes of Medullary thyroid cancer With and Without Amyloid Deposition.
Toraih E; Hussein M; Anker A; Baah S; Pinion D; Jishu J; Sadakkadulla S; Case M; LaForteza A; Moroz K; Kandil E
Endocr Pract; 2024 Apr; 30(4):311-318. PubMed ID: 38184237
[TBL] [Abstract] [Full Text] [Related]
5. The Clinical Utility of Gallium-68-DOTATATE Positron Emission Tomography Scanning in Medullary thyroid cancer.
Gild ML; Kumar S; Fuchs TL; Glover A; Sidhu S; Sywak M; Tsang V; Gill AJ; Robinson BG; Schembri G; Clifton-Bligh RJ; Hoang J
Endocr Pract; 2024 Mar; 30(3):218-224. PubMed ID: 38103829
[TBL] [Abstract] [Full Text] [Related]
6. Competing-risks model for predicting the prognostic value of lymph nodes in medullary thyroid carcinoma.
Shang F; Liu X; Ren X; Li Y; Cai L; Sun Y; Wen J; Zhai X
PLoS One; 2023; 18(10):e0292488. PubMed ID: 37844021
[TBL] [Abstract] [Full Text] [Related]
7. Association of the Genomic Profile of Medullary thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study.
Xu B; Viswanathan K; Ahadi MS; Ahmadi S; Alzumaili B; Bani MA; Baudin E; Behrman DB; Capelletti M; Chau NG; Chiarucci F; Chou A; Clifton-Bligh R; Coluccelli S; de Biase D; De Leo A; Dogan S; Fagin JA; Fuchs TL; Glover AR; Hadoux J; Lacroix L; Lamartina L; Lubin DJ; Luxford C; Magliocca K; Maloberti T; Mohanty AS; Najdawi F; Nigam A; Papachristos AJ; Repaci A; Robinson B; Scoazec JY; Shi Q; Sidhu S; Solaroli E; Sywak M; Tuttle RM; Untch B; Barletta JA; Al Ghuzlan A; Gill AJ; Ghossein R; Tallini G; Ganly I
Thyroid; 2024 Feb; 34(2):167-176. PubMed ID: 37842841
[No Abstract] [Full Text] [Related]
8. Risk factors for cervical lymph node metastasis in the central or lateral cervical region in medullary thyroid carcinoma: a systematic review and meta-analysis.
Lin X; Huo J; Su H; Zhu C; Xu Y; Zhang F
Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):547-561. PubMed ID: 37801162
[TBL] [Abstract] [Full Text] [Related]
9. Preoperative identification of low-risk medullary thyroid carcinoma: potential application to reduce total thyroidectomy.
Park H; Ryu HJ; Heo J; Chung MK; Son YI; Kim JH; Hahn SY; Shin JH; Oh YL; Kim SW; Chung JH; Kim JS; Kim TH
Sci Rep; 2023 Sep; 13(1):15663. PubMed ID: 37730953
[TBL] [Abstract] [Full Text] [Related]
10. The novel prognostic nomograms for predicting cancer-specific survival and overall survival in mixed medullary and follicular cell carcinoma: A SEER-based study.
Li Y; Guo T; Gao X; Liu J
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16337-16354. PubMed ID: 37704803
[TBL] [Abstract] [Full Text] [Related]
11. Preoperative neck ultrasound combined with pathological data can significantly impact the outcome of medullary thyroid carcinoma.
Deandrea M; Piticchio T; Mormile A; Retta F; Canale G; Caracciolo A; Daniele L; Trimboli P
Endocr J; 2023 Nov; 70(11):1061-1067. PubMed ID: 37690841
[TBL] [Abstract] [Full Text] [Related]
12. Appropriate and mindful measurement of serum calcitonin in patients with thyroid nodules. A white paper.
Trimboli P; Valderrabano P; Pitoia F; Piccardo A; Bojunga J
Endocrine; 2024 Jan; 83(1):60-64. PubMed ID: 37589814
[TBL] [Abstract] [Full Text] [Related]
13. Clinicopathological and prognostic significance of PD-L1 and TIM-3 expression in medullary thyroid carcinoma: a retrospective immunohistochemistry study.
Wusiman D; Guo L; Li L; Zhang X; Zhao X; An Z; Huang Z; Zhang Y; Li Z; Ying J; Wei M; Li W; An C
J Endocrinol Invest; 2024 Jan; 47(1):91-100. PubMed ID: 37464189
[TBL] [Abstract] [Full Text] [Related]
14. A Proposed Modified Staging System for Medullary thyroid cancer: A SEER Analysis With Multicenter Validation.
Wang Z; Fan X; Zha X; Xu Y; Yin Z; Rixiati Y; Yu F
Oncologist; 2024 Jan; 29(1):e59-e67. PubMed ID: 37311049
[TBL] [Abstract] [Full Text] [Related]
15. Medullary thyroid Carcinomas Classified According to the International Medullary Carcinoma Grading System and a Surveillance, Epidemiology, and End Results-Based Metastatic Risk Score: A Correlation With Genetic Profile and Angioinvasion.
Torricelli F; Santandrea G; Botti C; Ragazzi M; Vezzani S; Frasoldati A; Ghidini A; Giordano D; Zanetti E; Rossi T; Nicoli D; Ciarrocchi A; Piana S
Mod Pathol; 2023 Sep; 36(9):100244. PubMed ID: 37307881
[TBL] [Abstract] [Full Text] [Related]
16. Independent Validation of the International Grading System for Medullary thyroid Carcinoma: A Single Institution Experience.
Lubin DJ; Behrman DB; Goyal S; Magliocca K; Shi Q; Chen AY; Viswanathan K
Mod Pathol; 2023 Sep; 36(9):100235. PubMed ID: 37270155
[TBL] [Abstract] [Full Text] [Related]
17. Medullary thyroid cancer: Updates and Challenges.
Gild ML; Clifton-Bligh RJ; Wirth LJ; Robinson BG
Endocr Rev; 2023 Sep; 44(5):934-946. PubMed ID: 37204852
[TBL] [Abstract] [Full Text] [Related]
18. Looking for RET alterations in thyroid cancer: clinical relevance, methodology and timing.
Elisei R; Romei C
Endocrine; 2023 Aug; 81(2):206-215. PubMed ID: 37195581
[TBL] [Abstract] [Full Text] [Related]
19. Natural History and Predictive Factors of Outcome in Medullary thyroid Microcarcinoma.
Kesby N; Mechera R; Fuchs T; Papachristos A; Gild M; Tsang V; Clifton-Bligh R; Robinson B; Sywak M; Sidhu S; Chou A; Gill AJ; Glover A
J Clin Endocrinol Metab; 2023 Sep; 108(10):2626-2634. PubMed ID: 36964913
[TBL] [Abstract] [Full Text] [Related]
20. Value of lymph node ratio as a prognostic factor of recurrence in medullary thyroid cancer.
Hao W; Zhao J; Guo F; Gu P; Zhang J; Huang D; Ruan X; Zeng Y; Zheng X; Gao M
PeerJ; 2023; 11():e15025. PubMed ID: 36935920
[TBL] [Abstract] [Full Text] [Related]
[Next]
